Skin & hair

Mohs or Standard Excision — How the Choice Is Made

Save

The choice between Mohs and standard excision is not about which is more advanced. It is a match: the tumor's type, size, location, and how its edges behave decide which operation removes it with the fewest missed cells and the least damage. Here is how dermatologists and surgeons actually make that call.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

How the two operations actually differ

Both operations remove a skin cancer surgically, under local anesthesia, in an outpatient room — you are awake, the area is numb, and you go home the same day. The difference is how the edges are checked. Standard excision cuts out the visible tumor plus a set margin of normal-looking skin, closes the wound, and sends the specimen to a pathology lab that reads representative slices a few days later. Mohs micrographic surgery removes a thin saucer of tissue, then the surgeon maps it and examines the entire deep and outer margin under the microscope while you wait 1.

The reason that difference matters is what each method can see. Standard pathology cross-sections the specimen like a loaf of bread and inspects the cut faces — a careful sample, but a sample. Mohs is built to examine effectively the whole margin, which is why the word micrographic sits in its name: the cells a tumor regrows from are precisely the ones that trail off in a direction a sample can miss. If the Mohs map shows tumor still at an edge, the surgeon takes another thin layer from only that spot and checks again, repeating until the margin reads clear 1. Standard excision reaches the same certainty, but the answer arrives after the wound is closed — so a positive margin means going back for a second operation.

When is Mohs the right choice?

Mohs is chosen when a tumor sits where every millimeter of skin counts, or behaves in a way that makes its true edges hard to predict. A large multi-society panel rated 270 clinical scenarios to standardize this decision, and the pattern is consistent: high-risk anatomic sites, aggressive or ill-defined tumors, recurrent cancers, unusually large lesions, and tumors in people whose immune systems are suppressed all lean toward Mohs 2.

The classic high-risk zone is the central face — nose, eyelids, lips, ears, and the folds around them — along with the hands, feet, genitals, and nail units, where an ordinary excision margin would either miss tumor or remove tissue that cannot be spared 2. Histology matters just as much: subtypes with finger-like or scattered growth, such as infiltrative or morpheaform basal cell carcinoma, reach farther than the visible bump suggests, and the guidelines route high-risk basal cell carcinoma 1 and squamous cell carcinoma 3 toward Mohs for exactly that reason. A cancer that has returned after earlier treatment is, by definition, one whose borders the first operation misjudged — another Mohs indication.

Size and definition matter as much as location. A large tumor, or one whose borders fade into the surrounding skin so it is hard to say where the cancer stops, is difficult to excise with a confident margin, and both features push toward Mohs 2. So does a cancer arising in previously irradiated skin or within an old scar, and a tumor in someone whose immune system is suppressed — after an organ transplant, for example — where skin cancers tend to be more numerous, faster, and more aggressive 2. The appropriate use criteria fold all of these together rather than weighing any one in isolation, which is why two tumors of the same name can earn different operations. What happens during Mohs surgery — the layer-by-layer removal, the waiting while tissue is read, the same-day repair — is worth understanding before the appointment, because the rhythm of the day is unlike any other minor surgery.

When is standard excision the right choice?

Standard excision is the right operation for most skin cancers: low-risk basal and squamous cell carcinomas with well-defined borders on the trunk, arms, or legs, where there is enough surrounding skin to take a guideline-set margin and close the wound simply. For these tumors, excision cures at rates comparable to Mohs, in a single shorter visit, without the same-day laboratory 3.

The guidelines assign a standardized margin of normal-looking skin around a low-risk tumor — a few millimeters, calibrated to the cancer type — and delayed pathology confirms that margin afterward 13. Because the whole specimen reaches the lab intact, the pathologist can also grade the tumor and flag features that change how closely you are followed. Choosing excision is not settling for a lesser operation; it is matching a straightforward tumor to a straightforward removal. The mechanics overlap with a routine mole removal, but the margins and the pathology are what set cancer surgery apart. Overusing Mohs where it is not indicated adds time and cost without adding cure — which is exactly why the appropriate use criteria were written 2.

How melanoma changes the decision

Melanoma is treated differently from basal and squamous cell carcinoma. The standard operation for an invasive melanoma is wide local excision — removing the biopsy site with a margin that widens according to how deep the tumor grew — not conventional same-day Mohs 4. Margins are set by Breslow thickness, ranging from roughly a centimeter for thin tumors up to two centimeters for thick ones, and deeper tumors may also prompt a sentinel lymph node biopsy to check the nearest lymph nodes 45.

The exception is melanoma in situ of the lentigo maligna type — a slow, ill-defined pigmented patch, often on sun-damaged facial skin — where a staged excision or a Mohs-style technique is used precisely because the borders are so hard to see 4. For the deeper, invasive melanomas, the priority is a properly measured wide margin and accurate staging, which pathology of the full excision specimen provides 5. If you are facing this, wide local excision is the term to read up on, and the margin your surgeon quotes will map directly to your tumor's measured thickness rather than to how the spot looks.

What 'clear margins' means, and why it can take two operations

Clear margins means the pathologist finds no tumor cells at the cut edge of the tissue that was removed — the evidence that the whole cancer came out. Mohs pursues clear margins in real time, taking another thin layer the same day wherever the map still shows tumor, so you usually leave the appointment with the cancer confirmed gone. Standard excision confirms margins on delayed pathology, so a positive margin — tumor still sitting at an edge — means going back for a second removal.

That difference is the practical heart of the whole choice. On a low-risk tumor with predictable, well-defined edges, the chance of a positive margin is low, so the delay costs little and excision is efficient 3. On a tumor with ill-defined or infiltrative borders, the odds of leaving tumor behind climb, and the same-day certainty of Mohs avoids the loop of removing, waiting for pathology, learning it was not enough, and returning to cut again 1. It is a fair question to ask which outcome is more likely for your particular tumor, because the answer often makes the recommendation make sense on its own.

So which one is actually better?

Better depends on what you are optimizing. For the highest margin certainty and the most tissue spared on a cosmetically or functionally critical site, Mohs is better — that is what it was designed to do. For a low-risk tumor on forgiving skin, standard excision is better, because it reaches the same cure with less time and less complexity. Neither wins in the abstract; the tumor and its location decide.

A useful way to hear a recommendation is to ask which tumor features are driving it: location, type, size, whether it has recurred, and whether the borders are clear. Those are the same inputs the appropriate use criteria weigh 2, and a surgeon should be able to name the ones that tipped your case one way. The real question is not "which operation is best" but "which operation is right for this tumor, in this spot, in me." Scarring, recovery, and cost differ between the two, but they follow the tumor decision rather than driving it — a smaller wound that leaves cancer behind helps no one.

The biopsy comes first, and it drives everything

None of this is decided before there is a diagnosis. A skin biopsy — sampling the lesion so a pathologist can identify the exact cancer and, for melanoma, measure its depth — is what determines which operation is even on the table. For a suspected melanoma, the guidelines favor sampling the whole lesion at full thickness rather than taking a superficial shave, because a partial sample can under-measure depth and distort staging 6.

The biopsy result names the tumor type, its subtype, and its aggressiveness — the three things that route you toward Mohs, standard excision, or wide local excision. That is also why a page like this one cannot settle your case from a photo or a description: the plan is written from the pathology, not the appearance. Which skin biopsy technique fits a given lesion is itself a considered choice, made by the clinician who can see and feel the spot. If something is changing, bleeding, or refusing to heal, the move is to have it examined and, if warranted, biopsied — the diagnosis is what unlocks the right surgery.

What the day and the recovery look like

Both operations are outpatient and use local anesthesia, so you are awake and numb rather than asleep. Standard excision is usually a single visit of well under an hour. Mohs can run several hours, because of the waits between layers while each is mapped and read, with the repair done only once the margin is finally clear. Recovery for both is wound care over a couple of weeks.

The long part of a Mohs day is the laboratory work, not the cutting — you spend most of it waiting, often in the office, while a layer is processed and examined. Healing after Mohs surgery depends mostly on where the wound is and how it was closed, and the recovery and wound-care details are worth reading before you go in. Stitches, a small skin graft, or letting a minor wound close on its own are all possibilities, each chosen for the site and the size of the defect. A wound on the nose or near the eye is a different repair from one on the back, and the surgeon plans that closure as carefully as the removal itself.

Common questions

Not usually. Both are done under local anesthesia, so the removal itself is numb in either case. Mohs feels longer because of the waiting between layers, and a larger reconstruction can mean more soreness afterward, but the cutting is not more painful. Post-procedure discomfort tracks the size and location of the wound more than the method used to make it.

Often, because Mohs removes only the tissue that still contains tumor and spares the rest, which matters most on the face. But the final scar depends on the wound's size and how it is repaired, not on the method alone. On the trunk or limbs, a standard excision may scar no differently, which is part of why low-risk tumors there do not need Mohs.

For most invasive melanomas, no — the standard is wide local excision with margins set by tumor thickness. A Mohs-style staged technique is sometimes used for melanoma in situ of the lentigo maligna type, where the borders are very hard to see. The distinction is made by the biopsy result, so the diagnosis determines the operation rather than the other way around.

Most likely because the tumor is low-risk and sits on skin with room to spare — the trunk, an arm, a leg — with clear borders. Standard excision cures those at rates comparable to Mohs in a shorter visit. Mohs is reserved for higher-risk sites and tumors; using it where it is not needed adds time and cost without adding benefit.

Plan for most of a day, even though the actual surgery is brief. The time is spent waiting between layers while each is processed and read under the microscope, sometimes across two or more rounds. Once the margin is clear, the repair is done the same day. Many people bring something to read or work on during the waits.

The two are billed differently, and Mohs generally involves more of the surgeon's and laboratory's time. But cost follows the clinical decision rather than driving it: the right operation is the one matched to your tumor and its location. Coverage and out-of-pocket amounts vary, so asking your insurer and the office for an estimate ahead of time is reasonable.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a skin spot needs attention sooner

  • A spot that bleeds on its own, scabs, and then reopens in the same place over several weeks
  • A sore on the face, ear, lip, or scalp that has not healed in about a month
  • A previously treated skin-cancer site that develops a new bump, firmness, or color
  • A pigmented spot that is quickly changing in size, shape, or color, or a new pain, numbness, or tingling at a known skin-cancer site

This article explains how the choice between Mohs surgery and standard excision is made in general terms. It is not a diagnosis and cannot tell you which operation your tumor needs. A clinician who can examine the lesion and read its biopsy decides the plan. Bring your questions to that visit.

References

  1. 1.Kim JYS, Kozlow JH, Mittal B, et al. (2018). Guidelines of care for the management of basal cell carcinoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2017.10.006Basal cell carcinoma is diagnosed by biopsy and treated by standard surgical excision with guideline-set clinical margins, with Mohs micrographic surgery preferred for high-risk and facial tumors because it assesses the complete margin.
  2. 2.Ad Hoc Task Force (Connolly SM, Baker DR, Coldiron BM, et al.) (2012). AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2012.06.009Multi-society appropriate use criteria rate 270 clinical scenarios for Mohs by tumor and patient features, favoring high-risk anatomic sites, aggressive or ill-defined histology, recurrent and large tumors, and immunosuppression.
  3. 3.Kim JYS, Kozlow JH, Mittal B, et al. (2018). Guidelines of care for the management of cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2017.10.007Cutaneous squamous cell carcinoma is risk-stratified; low-risk tumors are treated with standard excision margins and high-risk tumors with Mohs micrographic surgery.
  4. 4.Swetter SM, Tsao H, Bichakjian CK, et al. (2019). Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2018.08.055Invasive melanoma is treated with wide local excision using margins set by Breslow thickness; staged excision or Mohs is used for lentigo maligna; sentinel lymph node biopsy is considered for deeper tumors.
  5. 5.National Cancer Institute (PDQ Adult Treatment Editorial Board) (2025). Melanoma Treatment (PDQ®)–Health Professional Version. NIH / National Cancer Institute. linkStandard melanoma treatment includes wide excision and sentinel lymph node biopsy, with staging drawn from the full excision specimen.
  6. 6.American Family Physician (2011). Shave and Punch Biopsy for Skin Lesions. American Family Physician. linkFor a suspected melanoma, narrow full-thickness (excisional or saucerization) sampling is preferred over a superficial shave or partial punch to preserve staging accuracy.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy